HCPCS code A9562: Mertiatide, per study dose2026 Medicare rate & RVUs

Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.

What A9562 covers

Technetium-99m mertiatide, also known as MAG3, is a radiopharmaceutical administered intravenously for nuclear medicine imaging of the kidneys. Nuclear medicine clinicians use the resulting images to assess renal blood flow, kidney function, and tracer drainage into the urinary tract, including when evaluating possible obstruction. Imaging may include a diuretic intervention when clinically indicated.

A9562 identifies the diagnostic radiopharmaceutical, not the renal imaging procedure. Its unit represents one study dose of up to 15 millicuries. Medicare physician fee schedule status C means there is no national physician fee schedule payment; the Medicare Administrative Contractor sets payment for each claim. HCPCS pricing likewise assigns payment to the contractor, and coverage is left to that contractor’s judgment. The related renal imaging procedure is reported with its applicable CPT code.

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

Where A9562 pays more and less

The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.

109 of 109 payment localities

A9562 rates by state

Office rate range in each state. Select a state to see its payment localities.

How the A9562 rate is calculated

Each of A9562’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.

Payment rules and modifiers for A9562

A9562 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.

A9562 compared with similar codes

How to choose

78707Renal imagingSingle study, no drug

This CPT code reports a single renal imaging study with vascular flow and function without pharmacologic intervention. A9562 identifies the mertiatide dose used for imaging.

78708Renal imagingPharmacologic intervention

This CPT code reports renal imaging with vascular flow and function when pharmacologic intervention is performed. A9562 identifies the radiopharmaceutical, not the intervention or imaging procedure.

A9551Tc-99m succimerPer study dose

A9551 identifies technetium-99m succimer for renal cortical imaging; A9562 identifies mertiatide used to assess renal function and tracer drainage.

Codes related to A9562

Related codes aren’t interchangeable: bill the code that matches the service performed.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.

CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027

Open CMS sourceHow we calculate rates